Preferred Label : Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931;
NCIt synonyms : Monovalent HPV18 Ad26-vectored Vaccine JNJ-63682931; Adenovirus Serotype 26-Human Papillomavirus 18 JNJ-63682931; Ad26.HPV18 JNJ-63682931; Ad26-expressing HPV18 Vaccine JNJ-63682931;
NCIt definition : A prime cancer vaccine comprised of a genetically engineered, replication-deficient
adenovirus serotype 26 (Ad26) encoding the oncogenic human papillomavirus 18 (HPV18),
with potential immunostimulating and antineoplastic activities. Upon intramuscular
administration of Ad26-expressing HPV18 vaccine JNJ-63682931, the adenovirus infects
and expresses HPV18. The expressed proteins stimulate the host immune system to mount
a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV18 antigens,
thereby inducing tumor cell lysis. HPV18 infection plays a key role in the development
of a variety of cancers.;
Molecule name : JNJ-63682931; JNJ 63682931;
NCI Metathesaurus CUI : CL972333;
Origin ID : C167361;
UMLS CUI : C5238492;
Semantic type(s)
concept_is_in_subset
has_target